Vrtovec, 2013 trial summary    PDF trial summary

A randomised clinical trial investigating the effect of Bone marrow progenitor cells versus control in patients with dilated cardiomyopathy

        Z

NCT01350310    Circ Res 2013;112:165-73  



Studied treatment intracoronary CD34+ cell transplantation
Control treatment



Patients patients with dilated cardiomyopathy
Group sizes55 / 55



Blindness Inclusion period
Follow-up duration Centers
Lost to FU geographical localisation
Primary endpoint Design



EndpointX1N1X0N0TE95% CI LVEF - -9 - -9 no data Peak VO2 (mL/kg/min) - -9 - -9 no data acute heart failure - -9 - -9 no data cardiac event - 55 - 55 no data NYHA class - -9 - -9 no data LV End-Systolic Volume - -9 - -9 no data Minnesota Living With Heart Failure Questionnaire - -9 - -9 no data ventricular tachycardia - -9 - -9 no data 6-min Walk, m - -9 - -9 no data NT-proBNP - -9 - -9 no data all-cause mortality - -9 - -9 no data NYHA deterioration - -9 - -9 no data0,22,01,0

Vrtovec B, Poglajen G, Lezaic L, Sever M, Domanovic D, Cernelc P, Socan A, Schrepfer S, Torre-Amione G, Haddad F, Wu JC Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up. Circ Res 2013;112:165-73     [PMID: 23065358]   link to pdf   add to Mendeley  

ClinicalTrial.gov record NCT01350310



Registering number NCT01350310 (see trial on clinicaltrials.gov)
Code Name